Recurrent primary biliary cirrhosis after liver transplantation

American Journal of Transplantation

Volumn 10, Issue 4, 2010, Pages 720-726

  Silveira, M G ^a   Talwalkar, J A ^a   Lindor, K D ^a   Wiesner, R H ^a  

^a MAYO CLINIC   (United States)

Author keywords

Autoimmune liver disease; Calcineurin inhibition; OLT; Orthotopic liver transplant; Recurrent disease

Indexed keywords

ALKALINE PHOSPHATASE; AZATHIOPRINE; CALCINEURIN INHIBITOR; CORTICOSTEROID; CYCLOSPORIN; LEUKOCYTE ANTIGEN; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; TACROLIMUS; URSODEOXYCHOLIC ACID;

AGE DISTRIBUTION; ALKALINE PHOSPHATASE BLOOD LEVEL; CLINICAL FEATURE; COLD ISCHEMIA; DISEASE COURSE; DRUG EFFICACY; FATIGUE; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; ISCHEMIA; KERATOCONJUNCTIVITIS SICCA; LIVER BIOPSY; LIVER TRANSPLANTATION; METABOLIC BONE DISEASE; ORGAN DONOR; PREVALENCE; PRIMARY BILIARY CIRRHOSIS; PRIORITY JOURNAL; PRURITUS; RECIPIENT; RECURRENT DISEASE; RISK FACTOR; SHORT SURVEY; TREATMENT INDICATION; XEROSTOMIA;

ADULT; AGE FACTORS; AGED; DISEASE PROGRESSION; HUMANS; IMMUNOSUPPRESSIVE AGENTS; LIVER CIRRHOSIS, BILIARY; LIVER TRANSPLANTATION; MIDDLE AGED; PREVALENCE; RECURRENCE;

EID: 77949872097     PISSN: 16006135     EISSN: 16006143     Source Type: Journal    
DOI: 10.1111/j.1600-6143.2010.03038.x     Document Type: Short Survey

References (37)

1. Talwalkar JA, Lindor KD. Primary biliary cirrhosis. Lancet 2003 362 : 53 61.
2. Neuberger J. Liver transplantation for primary biliary cirrhosis. Autoimmun Rev 2003 2 : 1 7.
3. Lee J, Belanger A, Doucette JT, Stanca C, Friedman S, Bach N. Transplantation trends in primary biliary cirrhosis. Clin Gastroenterol Hepatol 2007 5 : 1313 1315.
4. Liermann Garcia RF, Evangelista Garcia C, McMaster P, Neuberger J. Transplantation for primary biliary cirrhosis: Retrospective analysis of 400 patients in a single center. Hepatology (Baltimore, MD) 2001 33 : 22 27.
5. Mendes FD, Kim WR, Pedersen R, Therneau T, Lindor KD. Mortality attributable to cholestatic liver disease in the United States. Hepatology (Baltimore, MD) 2008 47 : 1241 1247.
6. Kim WR, Wiesner RH, Therneau TM et al. Optimal timing of liver transplantation for primary biliary cirrhosis. Hepatology (Baltimore, MD) 1998 28 : 33 38.
7. Neuberger J. Liver transplantation for primary biliary cirrhosis: Indications and risk of recurrence. J Hepatol 2003 39 : 142 148.
8. Neuberger J, Portmann B, Macdougall BR, Calne RY, Williams R. Recurrence of primary biliary cirrhosis after liver transplantation. N Engl J Med 1982 306 : 1 4.
9. Charatcharoenwitthaya P, Pimentel S, Talwalkar JA et al. Long-term survival and impact of ursodeoxycholic acid treatment for recurrent primary biliary cirrhosis after liver transplantation. Liver Transpl 2007 13 : 1236 1245.
10. Abu-Elmagd K, Demetris J, Rakela J et al. Transplantation for primary biliary cirrhosis: Disease recurrence and outcome in 421 patients. Hepatology 1997 26 : 176A.
11. Sanchez EQ, Levy MF, Goldstein RM et al. The changing clinical presentation of recurrent primary biliary cirrhosis after liver transplantation. Transplantation 2003 76 : 1583 1588.
12. Sylvestre PB, Batts KP, Burgart LJ, Poterucha JJ, Wiesner RH. Recurrence of primary biliary cirrhosis after liver transplantation: Histologic estimate of incidence and natural history. Liver Transpl 2003 9 : 1086 1093.
13. Abraham SC, Poterucha JJ, Rosen CB, Demetris AJ, Krasinskas AM. Histologic abnormalities are common in protocol liver allograft biopsies from patients with normal liver function tests. Am J Surg Pathol 2008 32 : 965 973.
14. Klein R, Huizenga JR, Gips CH, Berg PA. Antimitochondrial antibody profiles in patients with primary biliary cirrhosis before orthotopic liver transplantation and titres of antimitochondrial antibody-subtypes after transplantation. J Hepatol 1994 20 : 181 189.
15. Van de Water J, Gerson LB, Ferrell LD et al. Immunohistochemical evidence of disease recurrence after liver transplantation for primary biliary cirrhosis. Hepatology 1996 24 : 1079 1084.
16. Demetris AJ, Markus BH, Esquivel C et al. Pathologic analysis of liver transplantation for primary biliary cirrhosis. Hepatology 1988 8 : 939 947.
17. Neuberger J. Recurrent primary biliary cirrhosis. Liver Transpl 2003 9 : 539 546.
18. Levitsky J, Hart J, Cohen SM, Te HS. The effect of immunosuppressive regimens on the recurrence of primary biliary cirrhosis after liver transplantation. Liver Transpl 2003 9 : 733 736.
19. Khettry U, Anand N, Faul PN et al. Liver transplantation for primary biliary cirrhosis: A long-term pathologic study. Liver Transpl 2003 9 : 87 96.
20. Sebagh M, Farges O, Dubel L, Samuel D, Bismuth H, Reynes M. Histological features predictive of recurrence of primary biliary cirrhosis after liver transplantation. Transplantation 1998 65 : 1328 1333.
21. Mells G, Mann C, Hubscher S, Neuberger J. Late protocol liver biopsies in the liver allograft: A neglected investigation? Liver Transpl 2009 15 : 931 938.
22. Jacob DA, Bahra M, Schmidt SC et al. Mayo risk score for primary biliary cirrhosis: A useful tool for the prediction of course after liver transplantation? Ann Transplant 2008 13 : 35 42.
23. Buist LJ, Hubscher SG, Vickers C, Michell I, Neuberger J, McMaster P. Does liver transplantation cure primary biliary cirrhosis? Transplant Proc 1989 21 : 2402.
24. Balan V, Batts KP, Porayko MK, Krom RA, Ludwig J, Wiesner RH. Histological evidence for recurrence of primary biliary cirrhosis after liver transplantation. Hepatology (Baltimore, MD) 1993 18 : 1392 1398.
25. Jacob DA, Neumann UP, Bahra M et al. Long-term follow-up after recurrence of primary biliary cirrhosis after liver transplantation in 100 patients. Clin Transplant 2006 20 : 211 220.
26. Manousou P, Arvaniti V, Tsochatzis E et al. Primary Biliary Cirrhosis after liver transplantation: Influence of immunosuppression and HLA locus disparity. Liver Transpl 2010 16 : 64 73.
27. Hashimoto T, Sugawara Y, Makuuchi M. Impact of human leukocyte antigen mismatching on outcomes of living donor liver transplantation for primary biliary cirrhosis. Liver Transpl 2007 13 : 938 939.
28. Guy JE, Qian P, Lowell JA, Peters MG. Recurrent primary biliary cirrhosis: Peritransplant factors and ursodeoxycholic acid treatment post-liver transplant. Liver Transpl 2005 11 : 1252 1257.
29. Balan V, Ruppert K, Demetris AJ et al. Long-term outcome of human leukocyte antigen mismatching in liver transplantation: Results of the National Institute of Diabetes and Digestive and Kidney Diseases Liver Transplantation Database. Hepatology (Baltimore, MD) 2008 48 : 878 888.
30. Morioka D, Egawa H, Kasahara M et al. Impact of human leukocyte antigen mismatching on outcomes of living donor liver transplantation for primary biliary cirrhosis. Liver Transpl 2007 13 : 80 90.
31. Wong PY, Portmann B, O'Grady JG et al. Recurrence of primary biliary cirrhosis after liver transplantation following FK506-based immunosuppression. J Hepatol 1993 17 : 284 287.
32. Hubscher SG, Elias E, Buckels JA, Mayer AD, McMaster P, Neuberger JM. Primary biliary cirrhosis. Histological evidence of disease recurrence after liver transplantation. J Hepatol 1993 18 : 173 184.
33. Hashimoto E, Shimada M, Noguchi S et al. Disease recurrence after living liver transplantation for primary biliary cirrhosis: A clinical and histological follow-up study. Liver Transpl 2001 7 : 588 595.
34. Neuberger J, Gunson B, Hubscher S, Nightingale P. Immunosuppression affects the rate of recurrent primary biliary cirrhosis after liver transplantation. Liver Transpl 2004 10 : 488 491.
35. Gautam M, Cheruvattath R, Balan V. Recurrence of autoimmune liver disease after liver transplantation: A systematic review. Liver Transpl 2006 12 : 1813 1824.
36. Campsen J, Zimmerman M, Trotter J et al. Liver transplantation for primary biliary cirrhosis: Results of aggressive corticosteroid withdrawal. Transplant Proc 2009 41 : 1707 1712.
37. Rowe IA, Webb K, Gunson BK, Mehta N, Haque S, Neuberger J. The impact of disease recurrence on graft survival following liver transplantation: A single centre experience. Transpl Int 2008 21 : 459 465.